0.45Open0.42Pre Close3 Volume34 Open Interest5.00Strike Price134.00Turnover95.47%IV10.61%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.45Extrinsic Value100Contract SizeAmericanOptions Type-0.4172Delta0.3072Gamma11.31Leverage Ratio-0.0097Theta-0.0016Rho-4.72Eff Leverage0.0052Vega
Applied Therapeutics Stock Discussion
$Applied Therapeutics(APLT.US)$
The biopharmaceutical company said Thursday that the Food and Drug Administration now has a target action date of Nov. 28 for its application, compared with the previous date of Aug. 28.
The company's application is for govorestat in the treatment of Galactosemia, a rare genetic condition that makes patients unable to metab...
In a significant development for the healthcare sector and investors worldwide, Applied Therapeutics Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company, has announced the Food and Drug Administration's acceptance and priority review of t...
No comment yet